DALLAS, July 3 /PRNewswire/ -- The U. S. Food and Drug Administration recently warned that a commonly used contrast agent used to improve MRI images has been linked to a potentially fatal disease.
Depending on the thermodynamic complex stability, addition of the trivalent metal salts may cause transmetallation or recomplexing in the MRI contrast agents, resulting in the release of toxic Gd 3+ ...
After adjusting for gender, age, education level, baseline neurocognitive performance, and others, the authors reported gadolinium exposure was not a significant predictor of cognitive decline, ...
Compared to group I GBCAs, group II GBCAs appear safe for use in patients with severe kidney disease. In a recent analysis, the risk of NSF in patients with stage 4 or 5 CKD was less than 0.07% with ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Expecting mothers who undergo an MRI in their first trimester shouldn’t have much to worry about if it was a standard one, according to a recent study of more than 1.4 million women. But an MRI that ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Researchers have developed a potential ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 45 (Nov. 11, 2008), pp. 17232-17237 (6 pages) Accurate imaging of atherosclerosis is a growing necessity ...
Oct. 29 (UPI) --Chemicals used to improve images of the heart during MRI scans are unlikely to produce allergic reactions and other side effects in patients who take them, according to a study ...
Gadolinium-based contrast agents (GBCAs) are used in MRI and angiography. In 2014, Japanese researchers showed increased signal intensity in the brains of people who underwent repeated GBCA-imaging ...
Researchers have developed a manganese-based magnetic resonance imaging contrast agent, a potential alternative to gadolinium-based agents, which carry significant health risks for some patients. A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback